In our laboratory, we selected as the target receptor human epidermal growth factor receptor 2 (HER2) (20, 22, –, 27), a member of the epidermal growth factor receptor (EGFR) family of receptors, present in a subset of breast, ovary, stomach, and lung cancers. This evidence concerns the gene ERBB2 and lung carcinoma.